 | • レポートコード：QY7723NY55092 • 出版社/出版日：QYResearch / 2026年3月 • レポート形態：英語、PDF、110ページ • 納品方法：Eメール（納期：3日） • 産業分類：バイオ |
| Single User（1名様利用） | ￥663,000 (USD4,250) | ▷ お問い合わせ |
| Multi User（5名様利用） | ￥994,500 (USD6,375) | ▷ お問い合わせ |
| Corporate User（利用人数無制限） | ￥1,326,000 (USD8,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界の研究用抗体市場規模は2025年にXX百万米ドルであり、2026年から2032年の予測期間中に年平均成長率（CAGR）XX％で拡大し、2032年までにXX百万米ドルに達すると予測されています。 中国の研究用抗体メーカー上位4社は市場シェアの約40％を占めており、主要企業にはサーモフィッシャー、メルク、アブカム、セル・シグナリング・テクノロジー、BDなどが挙げられる。 世界の研究用抗体市場は、企業、地域（国）、種類、エンドユーザーごとに戦略的にセグメント化されています。本レポートは、2021年から2032年までの地域別、種類別、エンドユーザー別の売上高および予測に関するデータ駆動型の洞察を通じて、ステークホルダーが新たな機会を活用し、製品戦略を最適化し、競合他社を凌駕することを可能にします。 市場セグメンテーション 企業別： Abcam Merck CST Thermo Fisher R&D Systems BD Biolegend Proteintech ABclonal Bio-Rad Santa Cruz Biotechnology (SCBT) Novus Biologicals Genetex Abnova Abcepta Aviva Biosciences MBL BioXCell Sino Biological HuaBio タイプ別セグメント モノクローナル抗体 ポリクローナル抗体 エンドユーザー別セグメント 製薬・バイオテクノロジー企業 CRO/CDMO企業 学術・研究機関 その他 地域別 マクロ地域 - 北米 - 欧州 - アジア太平洋 - 南米 - 中東・アフリカ 地域別市場 北米 欧州 アジア太平洋 ラテンアメリカ 中東・アフリカ （その他の地域については、クライアントのニーズに応じてカスタマイズ可能です。） 第1章：レポートの範囲、エグゼクティブサマリー、および市場進化シナリオ（短期／中期／長期） 第2章：研究用抗体市場の規模および成長ポテンシャルに関する定量分析（グローバル、地域、国別レベル） 第3章：メーカーの競合ベンチマーク（売上高、市場シェア、M&A、研究開発の重点分野） 第4章：タイプ別セグメンテーション分析 – ブルーオーシャン市場の開拓 第5章：用途別セグメンテーション分析 – 高成長が見込まれる下流市場の機会 第6章：企業、タイプ、用途、顧客別の地域別売上高内訳 第7章：主要メーカーのプロファイル – 財務状況、製品ポートフォリオ、戦略的動向 第8章：市場ダイナミクス – 推進要因、抑制要因、規制の影響、およびリスク軽減戦略 第9章：実践的な結論と戦略的提言。 |
The global Research Antibodies market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Chinese top four manufacturers of Research Antibodies occupied for a share nearly 40 percent, key players are Thermo Fisher, Merck, Abcam, Cell Signalling Technology and BD, etc.
The global Research Antibodies market is strategically segmented by company, region (country), by Type, and by End User. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by End User for 2021-2032.
Market Segmentation
By Company:
Abcam
Merck
CST
Thermo Fisher
R&D Systems
BD
Biolegend
Proteintech
ABclonal
Bio-Rad
Santa Cruz Biotechnology (SCBT)
Novus Biologicals
Genetex
Abnova
Abcepta
Aviva Biosciences
MBL
BioXCell
Sino Biological
HuaBio
Segment by Type
Monoclonal Antibodies
Polyclonal Antibodies
Segment by End User
Pharmaceutical & Biotechnology Companies
CRO/CDMO Companies
Academic & Research Institutes
Others
By Region
Macro-Region
– North America
– Europe
– Asia-Pacific
– South America
– Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Research Antibodies market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Monoclonal Antibodies
1.2.3 Polyclonal Antibodies
1.3 Market by End User
1.3.1 Global Market Share by End User: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 CRO/CDMO Companies
1.3.4 Academic & Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Research Antibodies Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Research Antibodies Market Share by Revenue, by Region (2021-2026)
2.4 Global Research Antibodies Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Research Antibodies Market Size and Prospective (2021-2032)
2.5.2 Europe Research Antibodies Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Research Antibodies Market Size and Prospective (2021-2032)
2.5.4 Latin America Research Antibodies Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Research Antibodies Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Research Antibodies Historical Market Size by Type (2021-2026)
3.2 Global Research Antibodies Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Research Antibodies
4 Breakdown Data by End User
4.1 Global Research Antibodies Historical Market Size by End User (2021-2026)
4.2 Global Research Antibodies Forecasted Market Size by End User (2027-2032)
4.3 New Sources of Growth in Research Antibodies Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Research Antibodies Players by Revenue (2021-2026)
5.1.2 Global Research Antibodies Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Research Antibodies Revenue
5.4 Global Research Antibodies Market Concentration Analysis
5.4.1 Global Research Antibodies Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Research Antibodies Revenue in 2025
5.5 Global Key Players of Research Antibodies Head Offices and Areas Served
5.6 Global Key Players of Research Antibodies, Product and Application
5.7 Global Key Players of Research Antibodies, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Research Antibodies Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Research Antibodies Market Size by Type (2021-2026)
6.1.2.2 North America Research Antibodies Market Share by Type (2021-2026)
6.1.3 North America Market Size by End User
6.1.3.1 North America Research Antibodies Market Size by End User (2021-2026)
6.1.3.2 North America Research Antibodies Market Share by End User (2021-2026)
6.1.4 North America Research Antibodies Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Research Antibodies Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Research Antibodies Market Size by Type (2021-2026)
6.2.2.2 Europe Research Antibodies Market Share by Type (2021-2026)
6.2.3 Europe Market Size by End User
6.2.3.1 Europe Research Antibodies Market Size by End User (2021-2026)
6.2.3.2 Europe Research Antibodies Market Share by End User (2021-2026)
6.2.4 Europe Research Antibodies Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Research Antibodies Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Research Antibodies Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Research Antibodies Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by End User
6.3.3.1 Asia-Pacific Research Antibodies Market Size by End User (2021-2026)
6.3.3.2 Asia-Pacific Research Antibodies Market Share by End User (2021-2026)
6.3.4 Asia-Pacific Research Antibodies Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Research Antibodies Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Research Antibodies Market Size by Type (2021-2026)
6.4.2.2 Latin America Research Antibodies Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by End User
6.4.3.1 Latin America Research Antibodies Market Size by End User (2021-2026)
6.4.3.2 Latin America Research Antibodies Market Share by End User (2021-2026)
6.4.4 Latin America Research Antibodies Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Research Antibodies Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Research Antibodies Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Research Antibodies Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by End User
6.5.3.1 Middle East & Africa Research Antibodies Market Size by End User (2021-2026)
6.5.3.2 Middle East & Africa Research Antibodies Market Share by End User (2021-2026)
6.5.4 Middle East & Africa Research Antibodies Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 Abcam
7.1.1 Abcam Company Details
7.1.2 Abcam Business Overview
7.1.3 Abcam Research Antibodies Introduction
7.1.4 Abcam Revenue in Research Antibodies Business (2021-2026)
7.1.5 Abcam Recent Development
7.2 Merck
7.2.1 Merck Company Details
7.2.2 Merck Business Overview
7.2.3 Merck Research Antibodies Introduction
7.2.4 Merck Revenue in Research Antibodies Business (2021-2026)
7.2.5 Merck Recent Development
7.3 CST
7.3.1 CST Company Details
7.3.2 CST Business Overview
7.3.3 CST Research Antibodies Introduction
7.3.4 CST Revenue in Research Antibodies Business (2021-2026)
7.3.5 CST Recent Development
7.4 Thermo Fisher
7.4.1 Thermo Fisher Company Details
7.4.2 Thermo Fisher Business Overview
7.4.3 Thermo Fisher Research Antibodies Introduction
7.4.4 Thermo Fisher Revenue in Research Antibodies Business (2021-2026)
7.4.5 Thermo Fisher Recent Development
7.5 R&D Systems
7.5.1 R&D Systems Company Details
7.5.2 R&D Systems Business Overview
7.5.3 R&D Systems Research Antibodies Introduction
7.5.4 R&D Systems Revenue in Research Antibodies Business (2021-2026)
7.5.5 R&D Systems Recent Development
7.6 BD
7.6.1 BD Company Details
7.6.2 BD Business Overview
7.6.3 BD Research Antibodies Introduction
7.6.4 BD Revenue in Research Antibodies Business (2021-2026)
7.6.5 BD Recent Development
7.7 Biolegend
7.7.1 Biolegend Company Details
7.7.2 Biolegend Business Overview
7.7.3 Biolegend Research Antibodies Introduction
7.7.4 Biolegend Revenue in Research Antibodies Business (2021-2026)
7.7.5 Biolegend Recent Development
7.8 Proteintech
7.8.1 Proteintech Company Details
7.8.2 Proteintech Business Overview
7.8.3 Proteintech Research Antibodies Introduction
7.8.4 Proteintech Revenue in Research Antibodies Business (2021-2026)
7.8.5 Proteintech Recent Development
7.9 ABclonal
7.9.1 ABclonal Company Details
7.9.2 ABclonal Business Overview
7.9.3 ABclonal Research Antibodies Introduction
7.9.4 ABclonal Revenue in Research Antibodies Business (2021-2026)
7.9.5 ABclonal Recent Development
7.10 Bio-Rad
7.10.1 Bio-Rad Company Details
7.10.2 Bio-Rad Business Overview
7.10.3 Bio-Rad Research Antibodies Introduction
7.10.4 Bio-Rad Revenue in Research Antibodies Business (2021-2026)
7.10.5 Bio-Rad Recent Development
7.11 Santa Cruz Biotechnology (SCBT)
7.11.1 Santa Cruz Biotechnology (SCBT) Company Details
7.11.2 Santa Cruz Biotechnology (SCBT) Business Overview
7.11.3 Santa Cruz Biotechnology (SCBT) Research Antibodies Introduction
7.11.4 Santa Cruz Biotechnology (SCBT) Revenue in Research Antibodies Business (2021-2026)
7.11.5 Santa Cruz Biotechnology (SCBT) Recent Development
7.12 Novus Biologicals
7.12.1 Novus Biologicals Company Details
7.12.2 Novus Biologicals Business Overview
7.12.3 Novus Biologicals Research Antibodies Introduction
7.12.4 Novus Biologicals Revenue in Research Antibodies Business (2021-2026)
7.12.5 Novus Biologicals Recent Development
7.13 Genetex
7.13.1 Genetex Company Details
7.13.2 Genetex Business Overview
7.13.3 Genetex Research Antibodies Introduction
7.13.4 Genetex Revenue in Research Antibodies Business (2021-2026)
7.13.5 Genetex Recent Development
7.14 Abnova
7.14.1 Abnova Company Details
7.14.2 Abnova Business Overview
7.14.3 Abnova Research Antibodies Introduction
7.14.4 Abnova Revenue in Research Antibodies Business (2021-2026)
7.14.5 Abnova Recent Development
7.15 Abcepta
7.15.1 Abcepta Company Details
7.15.2 Abcepta Business Overview
7.15.3 Abcepta Research Antibodies Introduction
7.15.4 Abcepta Revenue in Research Antibodies Business (2021-2026)
7.15.5 Abcepta Recent Development
7.16 Aviva Biosciences
7.16.1 Aviva Biosciences Company Details
7.16.2 Aviva Biosciences Business Overview
7.16.3 Aviva Biosciences Research Antibodies Introduction
7.16.4 Aviva Biosciences Revenue in Research Antibodies Business (2021-2026)
7.16.5 Aviva Biosciences Recent Development
7.17 MBL
7.17.1 MBL Company Details
7.17.2 MBL Business Overview
7.17.3 MBL Research Antibodies Introduction
7.17.4 MBL Revenue in Research Antibodies Business (2021-2026)
7.17.5 MBL Recent Development
7.18 BioXCell
7.18.1 BioXCell Company Details
7.18.2 BioXCell Business Overview
7.18.3 BioXCell Research Antibodies Introduction
7.18.4 BioXCell Revenue in Research Antibodies Business (2021-2026)
7.18.5 BioXCell Recent Development
7.19 Sino Biological
7.19.1 Sino Biological Company Details
7.19.2 Sino Biological Business Overview
7.19.3 Sino Biological Research Antibodies Introduction
7.19.4 Sino Biological Revenue in Research Antibodies Business (2021-2026)
7.19.5 Sino Biological Recent Development
7.20 HuaBio
7.20.1 HuaBio Company Details
7.20.2 HuaBio Business Overview
7.20.3 HuaBio Research Antibodies Introduction
7.20.4 HuaBio Revenue in Research Antibodies Business (2021-2026)
7.20.5 HuaBio Recent Development
8 Research Antibodies Market Dynamics
8.1 Research Antibodies Industry Trends
8.2 Research Antibodies Market Drivers
8.3 Research Antibodies Market Challenges
8.4 Research Antibodies Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Research Antibodies Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Research Antibodies Market Size Growth by End User (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Research Antibodies Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Research Antibodies Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Research Antibodies Revenue Share by Region (2021-2026)
Table 6. Global Research Antibodies Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Research Antibodies Revenue Share Forecast by Region (2027-2032)
Table 8. Global Research Antibodies Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Research Antibodies Market Share by Revenue, by Type (2021-2026)
Table 10. Global Research Antibodies Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Research Antibodies Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Research Antibodies Market Size by End User (2021-2026) & (US$ Million)
Table 14. Global Research Antibodies Market Share by Revenue, by End User (2021-2026)
Table 15. Global Research Antibodies Forecasted Market Size by End User (2027-2032) & (US$ Million)
Table 16. Global Research Antibodies Market Share by Revenue, by End User (2027-2032)
Table 17. New Sources of Growth in Research Antibodies Applications
Table 18. Global Research Antibodies Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Research Antibodies Market Share by Players (2021-2026)
Table 20. Global Top Research Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Research Antibodies as of 2025)
Table 21. Ranking of Global Top Research Antibodies Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Research Antibodies Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Research Antibodies, Headquarters and Area Served
Table 24. Global Key Players of Research Antibodies, Product and Application
Table 25. Global Key Players of Research Antibodies, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Research Antibodies Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Research Antibodies Market Share by Revenue, by Company (2021-2026)
Table 29. North America Research Antibodies Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Research Antibodies Market Size by End User (2021-2026) & (US$ Million)
Table 31. Europe Research Antibodies Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Research Antibodies Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Research Antibodies Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Research Antibodies Market Size by End User (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Research Antibodies Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Research Antibodies Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Research Antibodies Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Research Antibodies Market Size by End User (2021-2026) & (US$ Million)
Table 39. Latin America Research Antibodies Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Research Antibodies Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Research Antibodies Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Research Antibodies Market Size by End User (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Research Antibodies Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Research Antibodies Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Research Antibodies Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Research Antibodies Market Size by End User (2021-2026) & (US$ Million)
Table 47. Abcam Company Details
Table 48. Abcam Business Overview
Table 49. Abcam Research Antibodies Product
Table 50. Abcam Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 51. Abcam Recent Development
Table 52. Merck Company Details
Table 53. Merck Business Overview
Table 54. Merck Research Antibodies Product
Table 55. Merck Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 56. Merck Recent Development
Table 57. CST Company Details
Table 58. CST Business Overview
Table 59. CST Research Antibodies Product
Table 60. CST Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 61. CST Recent Development
Table 62. Thermo Fisher Company Details
Table 63. Thermo Fisher Business Overview
Table 64. Thermo Fisher Research Antibodies Product
Table 65. Thermo Fisher Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 66. Thermo Fisher Recent Development
Table 67. R&D Systems Company Details
Table 68. R&D Systems Business Overview
Table 69. R&D Systems Research Antibodies Product
Table 70. R&D Systems Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 71. R&D Systems Recent Development
Table 72. BD Company Details
Table 73. BD Business Overview
Table 74. BD Research Antibodies Product
Table 75. BD Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 76. BD Recent Development
Table 77. Biolegend Company Details
Table 78. Biolegend Business Overview
Table 79. Biolegend Research Antibodies Product
Table 80. Biolegend Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 81. Biolegend Recent Development
Table 82. Proteintech Company Details
Table 83. Proteintech Business Overview
Table 84. Proteintech Research Antibodies Product
Table 85. Proteintech Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 86. Proteintech Recent Development
Table 87. ABclonal Company Details
Table 88. ABclonal Business Overview
Table 89. ABclonal Research Antibodies Product
Table 90. ABclonal Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 91. ABclonal Recent Development
Table 92. Bio-Rad Company Details
Table 93. Bio-Rad Business Overview
Table 94. Bio-Rad Research Antibodies Product
Table 95. Bio-Rad Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 96. Bio-Rad Recent Development
Table 97. Santa Cruz Biotechnology (SCBT) Company Details
Table 98. Santa Cruz Biotechnology (SCBT) Business Overview
Table 99. Santa Cruz Biotechnology (SCBT) Research Antibodies Product
Table 100. Santa Cruz Biotechnology (SCBT) Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 101. Santa Cruz Biotechnology (SCBT) Recent Development
Table 102. Novus Biologicals Company Details
Table 103. Novus Biologicals Business Overview
Table 104. Novus Biologicals Research Antibodies Product
Table 105. Novus Biologicals Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 106. Novus Biologicals Recent Development
Table 107. Genetex Company Details
Table 108. Genetex Business Overview
Table 109. Genetex Research Antibodies Product
Table 110. Genetex Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 111. Genetex Recent Development
Table 112. Abnova Company Details
Table 113. Abnova Business Overview
Table 114. Abnova Research Antibodies Product
Table 115. Abnova Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 116. Abnova Recent Development
Table 117. Abcepta Company Details
Table 118. Abcepta Business Overview
Table 119. Abcepta Research Antibodies Product
Table 120. Abcepta Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 121. Abcepta Recent Development
Table 122. Aviva Biosciences Company Details
Table 123. Aviva Biosciences Business Overview
Table 124. Aviva Biosciences Research Antibodies Product
Table 125. Aviva Biosciences Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 126. Aviva Biosciences Recent Development
Table 127. MBL Company Details
Table 128. MBL Business Overview
Table 129. MBL Research Antibodies Product
Table 130. MBL Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 131. MBL Recent Development
Table 132. BioXCell Company Details
Table 133. BioXCell Business Overview
Table 134. BioXCell Research Antibodies Product
Table 135. BioXCell Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 136. BioXCell Recent Development
Table 137. Sino Biological Company Details
Table 138. Sino Biological Business Overview
Table 139. Sino Biological Research Antibodies Product
Table 140. Sino Biological Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 141. Sino Biological Recent Development
Table 142. HuaBio Company Details
Table 143. HuaBio Business Overview
Table 144. HuaBio Research Antibodies Product
Table 145. HuaBio Revenue in Research Antibodies Business (2021-2026) & (US$ Million)
Table 146. HuaBio Recent Development
Table 147. Research Antibodies Market Trends
Table 148. Research Antibodies Market Drivers
Table 149. Research Antibodies Market Challenges
Table 150. Research Antibodies Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
研究用抗体の日本市場（2026年～2034年） Japan research antibodies market size reached USD 255.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 510.9 Million by 2034, exhibiting a growth rate (CAGR) of 8.00% during 2026-2034. Continuous medical advancements, coupled with the expanding biotechnology industry, …- 感情検出と認識の世界市場2025-2031 The global Emotion Detection and Recognition market size was US$ 16480 million in 2024 and is forecast to a readjusted size of US$ 67440 million by 2031 with a CAGR of 22.6% during the forecast period 2025-2031. The emotion detection and recognition is segmented by software tool, service, technology…
- 航空機向けギアの世界市場2026-2032 The global Aircraft Gears market size was US$ 377 million in 2025 and is forecast to reach a readjusted size of US$ 524 million by 2032 with a CAGR of 4.9% during the forecast period 2026-2032. Aircraft carry a variety of large and small gearboxes with approximately one thousand gear wheels distribu…
- インタラクティブキオスクの世界市場2026-2032 The global Interactive Kiosk market size was US$ 1198 million in 2025 and is forecast to reach a readjusted size of US$ 1746 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032. The Interactive Kiosk industry can be broken down into several segments, Less than 10 inch, 11~20 inc…
- タクシーの世界市場2026 According to our (Global Info Research) latest study, the global Taxi market size was valued at US$ xx million in 2025 and is forecast to a readjusted size of USD xx million by 2032 with a CAGR of xx% during review period. This report is a detailed and comprehensive analysis for global Taxi market. …